Fulton Breakefield Broenniman’s Humana HUM Stock Holding History

Fulton Breakefield Broenniman’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-965	Closed	-$448K	–	183
2021 Q4	$448K	Sell	965 -35	-4%	-$15.5K	0.03%	138
2021 Q3	$389K	Sell	1,000 -60	-6%	-$25.5K	0.03%	142
2021 Q2	$469K	Sell	1,060 -5	-0.5%	-$2.18K	0.04%	127
2021 Q1	$447K	Buy	+1,065	New	+$425K	0.04%	123
2020 Q4	–	Sell	-1,074	Closed	-$445K	–	154
2020 Q3	$445K	Sell	1,074 -19	-2%	-$7.64K	0.05%	112
2020 Q2	$424K	Buy	+1,093	New	+$409K	0.05%	116

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fulton Breakefield Broenniman's HUM Position: Q1 2022 in Review

Fulton Breakefield Broenniman sold out of Humana (HUM) in Q1 2022, closing a stake of 965 shares — an estimated $448K sold.

Fulton Breakefield Broenniman first reported a position in HUM in Q2 2020 and held it in 6 quarters. The position peaked at $469K in Q2 2021. 914 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

Fulton Breakefield Broenniman reported no remaining Humana position as of Q1 2022 after selling out during the quarter.
Fulton Breakefield Broenniman sold 965 Humana shares in Q1 2022, an estimated $448K.
Fulton Breakefield Broenniman first reported a position in Humana in Q2 2020 and held it in 6 quarters.
Fulton Breakefield Broenniman's Humana position peaked at $469K in Q2 2021.
914 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2022, filed 27 Apr 2022.